Nocturnal enuresis is a disorder in which episodes of urinary incontinence occurs during sleep in children ≥5 years of age. [1] More than 85% of children attain complete diurnal and nocturnal control of the bladder by 5 years of age. The remaining 15% gain continence at approximately 15% per year, such that by adolescence only 0.5%-1% children have enuresis. [2] Nocturnal enuresis prevalence rates vary from 3.5% to 56.4% in different geographical regions and countries. [3, 4] DSM-5 criteria for the diagnosis of enuresis are as follows: [5] • Repeated voiding of urine into bed or clothes, whether involuntary or intentional. • The behaviour either (a) occurs at least twice a week for at least 3 consecutive months or (b) results in clinically significant distress or social, functional or academic impairment. • The behaviour occurs in a child who is at least 5-year-old (or has reached the equivalent developmental level). • The behaviour cannot be attributed to the physiologic effects of a substance or other medical condition.
secondary enuresis such as bladder dysfunction, constipation, diabetes mellitus, hyperthyroidism, obstructive sleep apnoea, pinworm infestation and psychological stress. [8, 9] Studies suggest association between sexual abuse and nocturnal enuresis. [10] Active treatment should be avoided in children before the age of 6 years. The child should be reassured and no punitive measures to be taken as that can affect the child's psychological development adversely. The first line of treatment is usually non-pharmacological comprising motivational therapy and use of alarm devices. Alarm devices are used to elicit a conditioned response of awakening to the sensation of a full bladder. Pharmacotherapy is to be done if enuresis persists despite institution of alarm and regular voiding habits. [2, 6] Desmopressin acetate (DDAVP) is the preferred contemporary medication for treating children with enuresis. [6] However, the common side effects include headache, nausea, upset stomach or stomach pain, diarrhoea or flushing of the face (warmth, redness and tingly feeling). DDAVP can infrequently cause low levels of sodium in the blood, which can be serious and possibly life-threatening. [11] A randomised, double-blind, double-dummy, controlled trial [12] conducted by Ferrara et al. on 151 children suffering from nocturnal enuresis and treated with complex homoeopathic medicines (homotoxicological remedies) were superior to placebo (P < 0.001) with regard to the number of children attaining 14 consecutive dry nights during treatment, but less effective than standard treatment with Desmopressin. Naude [13] in his randomised, double-blind, placebo-controlled trial used homoeopathic complex remedies and evaluated against placebo; but it was under-reported. In a case series [14] of 27 patients, homoeopathic medicine Equisetum was coupled with a visualisation technique and the results were promising after 2 years of treatment. A Cochrane review [15] in 2011 could not identify any randomised trial of Homoeopathy for nocturnal enuresis in children and hence concluded that efficacy or effectiveness of Homoeopathy was uncertain in this condition. We identified one on-going single arm, open-label observational trial on 50 participants suffering from nocturnal enuresis evaluating the effects of homoeopathic medicine Causticum 200C (ClinicalTrials.gov Identifier: NCT02154152); however, no relevant publication could be identified. Thus, literature on homoeopathic medicines in the treatment of nocturnal enuresis with improvement in the quality of life was insufficient and required more studies for a clinical research decision on enuresis. The objective of this study was to evaluate the role of individualised homoeopathic medicines in the treatment of nocturnal enuresis.
mateRials and methods

Setting and design
A prospective, single arm, pre-post comparison, non-randomised, open-label, observational trial on individuals of 5-18 years of age presenting with nocturnal enuresis was conducted on the patients attending the outpatient departments at The Calcutta Homoeopathic Medical College and Hospital (CHMCH), Kolkata. The protocol was approved from the Institutional Ethical Committee of the institution. A total of 34 patients were included in the study. Each patient was provided with a patient information sheet in local vernacular Bengali detailing the objectives, methods, risks and benefits of participating and confidentiality issues. Before enrolment, written informed consent was taken from either of the parents or guardians of the patients.
Inclusion and exclusion criteria
Individuals of both sexes between 5 and 18 years of age with episodes of involuntary urination at least twice a week for 3 consecutive months, having no organic pathology behind enuresis, no anatomical and/or surgical changes leading to enuresis, and who have not used systemic antibiotics in the past 1 month, were enrolled. Patients whose parents did not give consent and had objection in being involved with the study were not included.
Outcome assessment
On account of the absence of any valid scales on nocturnal enuresis, we developed a nocturnal enuresis symptom severity scoring scale [ Table 1 ]; measured at baseline, and after the 2 nd and 4 th month were completed by one or both of the Table 3 .
Pre-post comparison
• Over 2 months: Compared to baseline, scores reduced significantly over 2 months (11.59 ± 1.99 vs. 9.56 ± 3.45;
parents with the help of the child under the guidance of the investigating physician. The assessment form consisted of ten questions with their respective scores ranging from 0 to 2 relating to the frequency of night wetting, experience of diurnal enuresis, urge for micturition, consciousness about enuresis after voiding and effects due to enuresis.
Intervention and follow-up
Each enrolled patient was enquired about the complaint according to the predesigned questionnaire. A careful history was obtained regarding whether the enuresis is primary or secondary, whether any daytime symptoms are present and whether any voiding difficulty is present. Enuresis-focused history, physical examination and urinalysis were done before initiation of treatment. Information was obtained to know the onset, duration and severity of enuresis; presence of daytime wetting, constipation, genitourinary symptoms and neurologic symptoms; family history of enuresis; patient medical and psychosocial history and details of previous treatment.
Medicines were prescribed after analysis and evaluation of symptom of each case. Cases were repertorised as and when required with the help of RADAR software version 10.0.028 (ck), Archibel 2007, Belgium. The selected medicines in appropriate doses were applied as per the directions in the Homoeopathic Philosophy. Medicines were repeated as per the individual requirement of each case and guidelines of Organon of Medicine. Intervention was given to each enrolled patient and follow up was conducted at least once a month (or earlier as required by the patient) for a timeline of 4 months as per the protocol.
Statistical analysis
Intention to treat analysis was conducted. Student's t-test and post hoc one-way repeated measure ANOVA were used keeping P < 0.05 two-tailed as statistically significant. Statistical Package for the Social Sciences, version 20.0 (IBM Corp., IBM SPSS Statistics for Windows, Armonk, NY: USA) was used for analysis.
Results
A total of 34 patients were enrolled in the study; 4 (11.76%) dropped out and 30 completed the study [ Figure 1 ].
Baseline features
The mean age of the participants was 8.71 ± 2.73 years; gender distribution was 1:1. Maximum number of patients spanned the age group of 8-10 years (47.1%). Among the participants, 55.9% children were studying in Class I to Class V, 64.7% belonged to middle economic status and 70.6% residing mostly in urban areas. Dietary habit was mostly non-vegetarian (91.2%). 70.59% of the parents did not have a history of nocturnal enuresis. Further details of the baseline socio-demographic characteristics are given in Table 2 .
Symptom profile
The frequency of night wetting was found to be daily in 79.4% patients that were subsequently reduced to 33.3% and 13.3% 
Medicines used
Kreosotum was the most frequently used medicine (n = 9; 26.5%), followed by Calcarea phosphorica (n = 6; 17.6%), Calcarea carbonica (n = 4; 11.7%), Cina and Acidum nitricum (n = 3; 8.8%) and Natrum muriaticum (n = 2; 5.9%). Rest of the medicines, namely Abrotanum, Aloe socotrina, Calcarea iodata, Chamomilla, Equisetum, Rhus toxicodendron and Tuberculinum were used once (n = 1; 2.9%) [ Table 4 and Figure 3 ]. Indication for Kreosotum was nocturnal enuresis specially in first sleep; the child was difficult to wake up even after bedwetting and dreams of urination as if urinating in the toilet during sleep was noted in one case. Calcarea phosphorica was prescribed for tall This prospective observational study was aimed to reflect the contemporary homoeopathic health care in real practice settings and its outcome in 34 patients suffering from nocturnal enuresis. The methodological strengths of our study include its prospective design, the participation of qualified and experienced homoeopathic physicians schooled in and practicing 'classical' Homoeopathy, and dealing with a challenging condition like nocturnal enuresis.
In the absence of control arm, there is always chance of overestimation of treatment effect sizes. This is attributable to placebo effect, regression effect to the mean and undisclosed use of concurrent therapeutic modalities. This issue could not be addressed in our study. Another limitation was the absence of prevalidated scale to measure the construct. We developed a scoring scale; however, its validity and reliability remained untested.
All the 34 patients were treated with homoeopathic medicines in different outpatient departments of the institution by different visiting physicians. After proper case taking medicines were selected on the basis of individualisation and totality of symptoms. The potency and dose selection for 
